The immune inhibitory mechanism could be related to the tumour itself, with the expression of PD-L1/B7-H1 and indoleamine 2,3-dioxygenase (IDO), the release of cytokines such as TGF-β and IL10, and the loss of MHC class I or class II expression [28]. This evidence concerns the gene CD274 and neoplasm.